RZLT
Rezolute Inc
NASDAQ · Biotechnology
$3.12
+0.20 (+6.85%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 45.23M | 44.79M | 46.31M |
| Net Income | 4.09M | 3.84M | 4.53M |
| EPS | — | — | — |
| Profit Margin | 9.0% | 8.6% | 9.8% |
| Rev Growth | +6.6% | +21.1% | +6.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 30.54M | 36.84M | 29.36M |
| Total Equity | 197.87M | 202.66M | 221.37M |
| D/E Ratio | 0.15 | 0.18 | 0.13 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 6.09M | 5.25M | 5.80M |
| Free Cash Flow | 2.47M | 3.54M | 3.43M |